Aurbindo Pharma

Rediff.com » News » Aurbindo Pharma

News for Aurbindo Pharma

News
Business

3 COVID vaccines under active consideration: Health ministry

Three COVID-19 vaccines, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of India's drug regulator and there is hope that early licensure is......

COVID vaccine likely to be available by first of 2021: Choubey

If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......

CBI special court issues summons to Jaganmohan Reddy

On a day when the Central Bureau of Investigation filed a third chargesheet in the disproportionate assets case against YS Jaganmohan Reddy, the CBI special court in Hyderabad issued a summons to......

Aurbindo Pharma ranks 2nd among Indian's pharma cos

With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales. P V......

India's outward FDI halves to $5.47 bn in June

Overseas investments by Indian companies halved to $5.47 billion in June, while Mundra Port and Bharti Airtel emerged as the top players in committing investments abroad.Outward flows totalled......

Aurbindo Pharma inks deal with AstraZeneca

Drugmaker Aurobindo Pharma on Monday said it has entered into licensing and supply agreements with London-based pharmaceutical giant AstraZeneca to supply several solid dosage and sterile products......

FCCB redemptions put India Inc in a spot

Indian companies that raised large sums of foreign funds to finance growth and acquisition plans during the bull run in the stock markets are in a Catch 22 situation. The conversion price of their......

Which stocks to buy now?

The Indian stock markets are soaring like there is no tomorrow. Starting at 13,000 in the beginning of this year, the Sensex crossed 20,000 by October.Will the Sensex sustain the gains or will it......

Rediff News

Aurbindo Pharma

News for Aurbindo Pharma

3 COVID vaccines under active consideration: Health ministry

COVID vaccine likely to be available by first of 2021: Choubey

CBI special court issues summons to Jaganmohan Reddy

Aurbindo Pharma ranks 2nd among Indian's pharma cos

India's outward FDI halves to $5.47 bn in June

Aurbindo Pharma inks deal with AstraZeneca

FCCB redemptions put India Inc in a spot

Which stocks to buy now?

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS